Finecare™ FIA Meter Plus
COVID-19
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| 2019-nCoV Antibody | Whole Blood Serum Plasma |
10μL | 10 mins | Qualitative | Negative |
| 2019-nCoV IgM | Qualitative | Negative | |||
| 2019-nCoV IgM/IgG | Qualitative | Negative | |||
| 2019-nCoV Antigen | NP/OP | / | 15 mins | Qualitative | Negative |
| 2019-nCoV RBD Antibody | Fingerstick or Venous WB/S/P | 20μL | 15 mins | Qualitative | Negative |
Diabetes & Renal injury
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| HbA1c | Whole Blood (Fingerstick/Venous) |
10μL | 5 mins | 4.0-14.5% | 4-6.5% |
| MAU | Urine | 75μL | 3 mins | 5-300 mg/L | 0-20 mg/L |
| CysC | Whole Blood Serum Plasma |
10μL | 5 mins | 0.2-10 mg/L | 0.5-1.1mg/L |
| β2-MG | Whole Blood Serum Plasma |
10μL | 10 mins | 0.3-20 mg/L | 1.0-2.7 mg/L |
| NGAL | Urine | 75μL | 15 mins | 10-1500 ng/mL | ≤131.7ng/mL |
Thyroid Function
Toggle Content goes here
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| T3 | Whole Blood Serum Plasma |
75μL | 15 mins | 0.61-9.22nmol/L | 1.23-3.07nmol/L |
| T4 | 12.87-300nmol/L | 66-181 nom/L | |||
| TSH | 0.1-100 mlU/L | 0.3-4.2mlU/L | |||
| fT3 | 0.40-50.00pmol/L (0.26-32.55pg/mL) |
2.8-7.1pmol/L (1.82-4.61 pg/ml) |
|||
| fT4 | 1.00-100 pmol/L (0.078-7.77ng/dl) |
12-22 pmol/L (0.94-1.72 ng/dL) |
Fertility
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| β-HCG | Whole Blood Serum Plasma |
20μL | 15 mins | 2-200,000mlU/mL | 5 mlU/mL |
| LH | Whole Blood Serum Plasma |
75μL | 15 mins | 1-100mlU/mL | Male: 1.70-8.60 mIU/mL; Female: Follicular phase: 2.95-13.65 mIU/mL Ovulation phase：13.65-95.75 mIU/mL Luteal phase：1.25-11.00 mIU/mL Menopause phase：8.24-55.23 mIU/mL |
| FSH | Whole Blood Serum Plasma |
75μL | 15 mins | 1-100mlU/mL | Male: 1.50-12.40 mIU/mL Female: Follicular phase：4.46-12.43 mIU/mL Ovulation phase：4.88-20.96 mIU/mL Luteal phase：1.96-7.70 mIU/mL Menopause phase： 22.70-130.00 mIU/mL |
| Prog | Whole Blood Serum Plasma |
75μL | 15 mins | 1.5-60ng/mL | Male: 0.2-1.5 ng/mL Female: Follicular phase: 0.2-2.0 ng/mL Ovulation phase: 0.7-3.5 ng/mL Luteal phase: 3.0-30 ng/mL Menopause phase: 0.1-0.9 ng/mL 7 weeks of pregnancy: 24.5±7.6 ng/mL 9-12 weeks of pregnancy: 38.0±13.0 ng/mL |
| PRL | Whole Blood Serum Plasma |
75μL | 15 mins | 1-200ng/mL | Female（non-pregnant): 4.60-25.07 ng/mL Male: 3.45-17.42 ng/mL |
| E2 | Whole Blood Serum Plasma |
75μL | 15 mins | 9-3000pg/mL | Male: <85 pg/mL Female: Follicular Phase: 12-262 pg/mL Ovulation: 40-396 pg/mL Luteal Phase: 21-381 pg/mL Menopause: <190 pg/mL Pregnancy: >145 pg/mL |
| Testosterone | Whole Blood Serum Plasma |
75μL | 15 mins | 0.2-15ng/mL | Male: 20-49 years old, 1.61-8.41 ng/mL ≥50 years old, <0.61 ng/mL Female: 20-49 years old, ≤0.80 ng/mL ≥50 years old, <0.71 ng/mL |
| AMH | Whole Blood Serum Plasma |
75μL | 15 mins | 0.1-16ng/mL | Male: 20-60 years old, 0.92-13.89 ng/mL Female： 20-29 years old, 0.88-10.35 ng/mL 30-39 years old, 0.31-7.86 ng/mL 40-50 years old, ≤5.07 ng/mL |
Cardiac Markers
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| NT-proBNP | Whole Blood Serum Plasma |
75μL | 15 mins | 18-35000pg/mL | ＜75 years old 0-300 pg/mL ≥ 75 years old 0-450 pg/mL |
| CTnI | 0.1-50ng/mL | 0-0.3 ng/mL | |||
| Myo | 2.0-400ng/mL | 0-58 ng/mL | |||
| CK-MB | 0.3-100ng/mL | 0-5 ng/mL | |||
| 3 in 1 (cTnl/MYO/CK-MB) |
Same with the single item | Same with the single item | |||
| BNP | Whole Blood Plasma |
5-5000pg/mL | 0-100 pg/mL | ||
| H-FABP | Whole Blood Serum Plasma |
1-120ng/mL | 0-7ng/mL | ||
| 2 in 1 (cTnl/NT-proBNP） |
Same with the single item | Same with the single item | |||
| hsCRP | 10μL | 3 mins | 0.1-10 mg/L | ≤1.0 mg/L | |
| cTnT | 100μL for whole blood; 75μL for plasma/serum |
15 mins | 0.003-10 ng/mL | 0-0.1 ng/mL | |
| Lp-PLA2 | 75μL | 10-1000 ng/mL | ＜225 ng/mL |
Coagulation
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| D-Dimer | Whole Blood Plasma |
15μL for whole blood 10μL for plasma |
5 mins | 0.1-10 mg/L | 0-0.5 mg/L |
| D-Dimer one-step |
100μL for whole blood 75μL for plasma |
15 mins | 0.1-10 mg/L | 0-0.5 mg/L |
Inflammation Markers
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| PCT | Whole Blood Serum Plasma |
75μL for whole blood 50 μL for serum/plasma |
15 mins | 0.1-100ng/mL | 0-0.5 ng/L |
| CRP (hsCRP+CRP) | 8.5μL for whole blood 5 μL for serum/plasma |
3 mins | 0.5-200mg/L | CRP: 0-10 mg/L HsCRP: 0-1 mg/L |
|
| SAA | 10μL | 15 mins | 1.0-300mg/L | 0-10 mg/L | |
| 2 in 1 (CRP+PCT) | 75μL | CPR: 0.5-150mg/L PCT: 0.1-100mg/L |
CPR: ＜10mg/L PCT: ＜0.5mg/L |
||
| IL-6 | 75μL | 3-4000 pg/Ml | ≤10 pg/mL |
Tumor Markers
| Items | Sample Types | Sample Size | Reaction Time | Measuring Range | Clinical Reference |
| AFP | Whole Blood Serum Plasma |
75μL | 15 mins | 5-400 ng/mL | 0-20 ng/mL |
| PSA | 2-100 ng/mL | 0-4 ng/mL | |||
| CEA | 1-500 ng/mL | 0-5 ng/mL | |||
| fPSA | 0.2-30 ng/mL | ＜1 ng/mL |
Others
| Items | Sample Size | Reaction Time | Qualifications |
| Cortisol | 75μL | 15 mins | NMPA |
| Vitamin D | CE, NMPA | ||
| S100β | NMPA | ||
| Ferritin | 10 mins | CE |
| Description | |
| Technologies | Built-in thermal printer 8” LED touch screen LIS/HIS connection ID Chip |
| Sample size | 75μ |
| Standards | CE, NMPA, NGSP, IFCC |
| Dimension | 270x238x146mm |
| Weight | 2.8kg |
| Application | Laboratory, ER, ICU, Clinics, GP office, Ambulance, etc. |